SCHEMBL6437703

CC[C@H](C)[C@H](NC(=O)[C@@H](N)CCCNC(=N)N)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)O

nearest known ligand 0.73

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	TFPI	P10646	1/20	0.63

▸	KISS1R	Q969F8	2/20	0.58

▸	VIPR1	P32241	3/20	0.57

▸	VIPR2	P41587	3/20	0.56

▸	NMUR2	Q9GZQ4	1/20	0.56

▸	NMUR1	Q9HB89	1/20	0.56

▸	ECE1	P42892	1/20	0.56

▸	GLP1R	P43220	1/20	0.56

▸	MUS81	Q96NY9	1/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL6437697	1.00	TFPI (0.63)	TFPIKISS1RVIPR1VIPR2NMUR2
SCHEMBL29746772	0.98	KISS1R (0.60)	TFPIKISS1RVIPR1VIPR2NMUR2
SCHEMBL6461324	0.94	TFPI (0.59)	TFPIVIPR1VIPR2ECE1GLP1R
SCHEMBL29922901	0.94	TFPI (0.59)	TFPIVIPR1VIPR2ECE1GLP1R
SCHEMBL29353526	0.92	TFPI (0.59)	TFPIVIPR1VIPR2GLP1R
SCHEMBL30367254	0.92	TFPI (0.59)	TFPIVIPR1VIPR2GLP1R
SCHEMBL29494169	0.92	KISS1R (0.60)	TFPIKISS1RVIPR1VIPR2ECE1
SCHEMBL29746571	0.91	TFPI (0.60)	TFPIKISS1RNMUR2NMUR1
SCHEMBL30449457	0.90	TFPI (0.68)	TFPINMUR2NMUR1
SCHEMBL29746858	0.90	PTH1R (0.60)	TFPIVIPR1VIPR2GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-1501605-A1	NOVEL USE OF GUANYLATE CYCLASE ACTIVATORS FOR THE TREATMENT OF RESPIRATORY INSUFFICIENCY	ALTANA Pharma AG (DE)	2005-02-02	—	—	EP	claimed
WO-2003090870-A1	NOVEL USE OF GUANYLATE CYCLASE ACTIVATORS FOR THE TREATMENT OF RESPIRATORY INSUFFICIENCY	ALTANA PHARMA AG (DE)	2003-11-06	—	—	WO	claimed